An Exploratory, Open Label, Single Center Study of [F-18]HX4
NCT00606424
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
10
Enrollment
INDUSTRY
Sponsor class
Conditions
Head and Neck Cancer
Interventions
DRUG:
20 mCi dose for a 50 kg individual of [F-18]HX4
Sponsor
Siemens Molecular Imaging